Skip to main content
Clinical Trials/ACTRN12616000717459
ACTRN12616000717459
Suspended
未知

A Feasibility Study to Assess Safety and Efficacy of the Transapical and Transfemoral JenaValve Pericardial TAVR (Transcatheter Aortic Valve Replacement) System in the Treatment of Patients with Symptomatic Severe Aortic Stenosis (AS)

JenaValve Technology, Inc.0 sites30 target enrollmentMay 30, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Aortic Stenosis
Sponsor
JenaValve Technology, Inc.
Enrollment
30
Status
Suspended
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient with severe degenerative native aortic stenosis (AS)
  • 2\.Patient at high risk for open surgical valve replacement
  • 3\.Patient symptomatic according to NYHA functional class II or higher

Exclusion Criteria

  • 1\.Congenital uni\- or bicuspid aortic valve morphology
  • 2\.Previous prosthetic aortic valve (bioprosthesis or mechanical) implant
  • 3\.Endocarditis or other active infection
  • 4\.Need for urgent or emergent TAVR procedure for any reason
  • 5\.Cardiogenic shock or hemodynamic instability requiring inotropic support or ventricular assist device

Outcomes

Primary Outcomes

Not specified

Similar Trials